Project Details
Description
Safety and efficacy of an oral piperidine-based, reversible inhibitor of acetylcholinesterase in client-owned dogs with allergic skin disease
| Status | Finished |
|---|---|
| Effective start/end date | 6/1/20 → 9/30/22 |
Funding
- NEURODERMA LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.